Virax Biolabs Group Ltd (VRAX) Capital expenditures 2024–2025
Virax Biolabs Group Ltd (VRAX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$603,890FY2025 · since FY2024: $952,497 → $603,890
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $603,890 | -36.6% |
| FY2024 | $952,497 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice